Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
Tannock IF; de Wit R; Berry WR; Horti J; Pluzanska A; Chi KN; Oudard S; Théodore C; James ND; Turesson I; Rosenthal MA; Eisenberger MA; The New England Journal Of Medicine, 2004, vol. 351, issue 15, p 1502, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation